Enhancement of cisplatin nephrotoxicity by probenecid.
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002945:Cisplatin / Q000009:adverse effects* / Q000378:metabolism; D004357:Drug Synergism; D005260:Female; D007674:Kidney Diseases / Q000139:chemically induced*; D008297:Male; D011339:Probenecid / Q000009:adverse effects*; D051381:Rats; D011919:Rats, Inbred Strains
D011339:Probenecid; D002945:Cisplatin